PBYI
Puma Biotechnology IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$357.82M
P/E Ratio
14.65
EPS
$0.48
Beta
1.21
52W High
$7.90
52W Low
$3.03
50-Day MA
$7.14
200-Day MA
$6.02
Dividend Yield
—
Profit Margin
10.70%
Forward P/E
3.46
PEG Ratio
0.03
About Puma Biotechnology Inc
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States and internationally. The company is headquartered in Los Angeles, California.
Fundamentals
| Revenue (TTM) | $227.18M |
| Gross Profit (TTM) | $169.15M |
| EBITDA | $39.41M |
| Operating Margin | -8.54% |
| Return on Equity | 21.60% |
| Return on Assets | 9.48% |
| Revenue/Share (TTM) | $4.51 |
| Book Value | $2.52 |
| Price-to-Book | 2.78 |
| Price-to-Sales (TTM) | 1.57 |
| EV/Revenue | 1.193 |
| EV/EBITDA | 6.02 |
| Quarterly Earnings Growth (YoY) | -34.40% |
| Quarterly Revenue Growth (YoY) | -2.60% |
| Shares Outstanding | $50.90M |
| Float | $39.09M |
| % Insiders | 15.38% |
| % Institutions | 77.52% |
Historical Volatility
HV 10-Day
28.16%
HV 20-Day
34.08%
HV 30-Day
30.43%
HV 60-Day
36.31%
HV Rank
1.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($5.00 target)
1
HoldMore HEALTHCARE Stocks
Data last updated: 6/6/2026